Equities

Modern Chinese Medicine Group Co Ltd

Modern Chinese Medicine Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.34
  • Today's Change0.00 / 0.00%
  • Shares traded612.00k
  • 1 Year change-27.66%
  • Beta0.5822
Data delayed at least 15 minutes, as of Jul 25 2024 08:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Modern Chinese Medicine Group Co Ltd is a China-based investment holding company that mainly produces Chinese patent medicines. The Company mainly provides over-the-counter (OTC) and prescribed medicine intended for use by the middle-aged and elderly people. The Company's main products are Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxremoving Pill. The Company is also engaged in the production of other traditional Chinese medicines designed to treat or relieve other conditions such as psychological, respiratory, and pediatric conditions. The Company mainly conducts business within the domestic market.

  • Revenue in HKD (TTM)371.45m
  • Net income in HKD52.68m
  • Incorporated2019
  • Employees191.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sanai Health Industry Group Co Ltd131.81m20.12m61.16m68.002.890.17993.430.4640.00550.00550.03480.08890.3179188.038.441,938,439.003.482.314.723.6528.7734.8710.956.566.22--0.18810.00-30.6016.04-36.23---75.21--
China NT Pharma Group Co Ltd7.95m-36.16m81.87m16.00------10.30-0.1828-0.78360.0377-1.390.0115.870.337497,008.90-5.02-12.34---163.52710.06---454.67-128.280.0185--64.15-----58.1233.07---46.32--
Extrawell Pharmaceutical Holdings Ltd59.10m-162.95m83.65m159.00--0.0752--1.42-0.0682-0.06820.02470.46570.04335.9011.81371,685.50-11.831.01-12.321.0648.7050.54-273.5118.003.31-0.05540.0977---18.57-7.91-226.06------
Regent Pacific Group Ltd2.47m-195.54m94.80m17.00------38.31-0.8685-0.86850.011-0.0530.0218--12.19145,566.40-172.08-50.00-694.26-59.04-----7,901.89-2,685.21--------574.47-44.7231.24---50.60--
Canbridge Pharmaceuticals Inc111.06m-408.98m150.82m100.00------1.36-0.9638-0.96380.2617-0.10120.18754.164.091,110,569.00-69.04---154.20--62.37---368.26--0.6132-41.341.39--30.26--21.64------
Kontafarma China Holdings Ltd809.11m-28.84m184.42m720.00--0.17444.170.2279-0.0052-0.00520.1450.18920.42063.227.031,123,760.00-3.18-1.33-4.22-2.1858.2554.70-7.55-4.121.28-17.160.2392---9.50-17.3266.02---19.55--
Modern Chinese Medicine Group Co Ltd371.45m52.68m204.00m191.003.870.39963.440.54920.08780.08780.61910.85090.66815.453.801,944,788.009.4720.7610.7525.8230.2841.0214.1820.117.98206.120.00022.54-13.9114.67-44.440.230396.96--
Shenzhen Neptunus Intrlng Bi tchnq CoLtd1.13bn29.32m243.31m1.44k8.30--11.120.21560.01750.01750.6726--------781,623.60--3.46--5.1339.4849.141.464.29--109.94--0.007.924.19-55.60-12.89-11.10--
PuraPharm Corp Ltd406.86m-106.08m277.13m662.00--1.81--0.6811-0.2685-0.26851.030.38710.43741.044.21614,590.60-11.40-9.20-34.00-19.7053.2459.52-26.07-19.330.3046-2.020.7349---9.20-11.4111.76---13.68--
Hin Sang Group (Interntnl) Hldng Co Ltd92.62m-36.71m300.24m265.00--1.44--3.24-0.0336-0.03360.08480.19130.15362.348.44---6.04-5.11-9.78-7.0461.9859.72-39.30-28.420.1287-1.810.6054--13.70-12.8325.84------
Uni-Bio Science Group Ltd484.72m70.88m351.32m407.005.121.394.000.72480.01110.01110.07620.0411.382.6213.501,190,953.0020.181.4628.501.9781.0480.5914.621.231.7697.930.17960.0010.0829.0884.04--84.98--
Wai Yuen Tong Medicine Holdings Limited783.88m-26.68m388.16m810.00--0.29134.740.4952-0.0228-0.01320.66361.180.17210.400110.55967,754.30-0.1597-0.3053-0.2538-0.520650.3743.82-0.928-2.181.372.130.2879--8.330.8488-62.16--15.35--
Data as of Jul 25 2024. Currency figures normalised to Modern Chinese Medicine Group Co Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.